Arran AE, Coburn E, Jacobsen J, Kuhn CM (2013) Lower anxiogenic effects of serotonin agonists are associated with lower activation of amygdala and lateral orbital cortex in adolescent male rats. Neuropharmacology 73:359–367

Article  Google Scholar 

Belzung C, Misslin R, Vogel E, Dodd RH, Chapouthier G (1987) Anxiogenic effects of methyl-carboline-carboxylate in a light/dark choice situation. Pharmacol Biochem Behav 28:29–33

Article  CAS  PubMed  Google Scholar 

Bisset WL, Butler AR, Glidewell C, Reglinski J (1981) Sodium nitroprusside and cyanide release Reasons for re-appraisal. Br J Anesthesiol 53:1015–1018

Bjork L, Frederiksson A, Hacksell U, Lewander T (1992) Effects of (R)-8-OHDPAT and the enantiomers of UH-301 on motor activities in the rat: Antagonism of (R)-8-OH-DPAT-induced effects. Eur Neuropharmacol 2:141–147

Braga RJ, Reynolds GP, Siris SG (2013) Anxiety comorbidity in schizophrenia. Psychiatry Res 210:1–7

Article  PubMed  Google Scholar 

Bredt DS, Glatt CE, Hwang PM, Fotuhi M, Dawson TM, Snyder SH (1991) Nitric oxide synthase protein and mRNA are discretely localized in neuronal populations of the mammalian CNS together with NADPH diaphorase. Neuron 7:615–624

Article  CAS  PubMed  Google Scholar 

Castel H, Vaudry H (2001) Nitric oxide directly activates GABAA receptor function through a cGMP/protein kinase-independent pathway in frog pituitary melanotrophs. J Neuroendocrinol 13:695–705

Article  CAS  PubMed  Google Scholar 

Chiavegatto S, Nelson RJ (2003) Interaction of nitric oxide and serotonin in aggressive behavior. Horm Behav 44:233–241

Article  CAS  PubMed  Google Scholar 

Crawley JN, Goodwin FK (1980) Preliminary report of a simple animal behavior for the anxiolytic effect of benzodiazepines. Pharmacol Biochem Behav 13:167–170

Article  CAS  PubMed  Google Scholar 

Cryan JF, Sweeney FF (2011) The age of anxiety. role of animal models of anxiolytic action in drug discovery Br J Pharmacol 164:1129–1161

Dawson TM, Snyder SH (1994) Gases as biological messengers: nitric oxide and carbon monoxide in the brain. J Neurosci 14:5147–5159

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dawson TM, Bredt DS, Fotuhi M, Hwang PM, Snyder SH (1991) Nitric oxide synthase and neuronal NADPH diaphorase are identical in brain and peripheral tissues. Proc Natl Acad Sci USA 88:7797–7801

Article  CAS  PubMed  PubMed Central  Google Scholar 

De Almeida RMM, Giovenardi M, Charchat H, Lucion AB (1998) 8-OH-DPAT in the medial raphe decreases while in the medial septal area it may increase anxiety in female rats. Neurosci Biobehav Rev 23:259–264

Article  PubMed  Google Scholar 

Elfline GS, Branda EM, Babich M, Quock RM (2004) Antagonism by NOS inhibition of the behavioural effects of benzodiazepine and GABAA receptor agonists in the mouse elevated plus-maze. Neuropsychopharmacology 29:1419–1425

Article  CAS  PubMed  Google Scholar 

Engin E, Treit D (2008) The effects of intra-cerebral drug infusions on animals’ unconditioned fear reactions: a systematic review. Prog Neuropsychopharmacol Biol Psychiatry 32:1399–1419

File SE, Gonzalez LE, Andrews N (1996) Comparative study of pre- and postsynaptic 5-HT1A receptor modulation of anxiety in two ethological animal tests. J Neurosci 16:4810–4815

Article  CAS  PubMed  PubMed Central  Google Scholar 

Garthwaite J (1991) Glutamate nitric oxide and cell-cell signalling in the nervous system. Trends Neurosci 14:60–67

Article  CAS  PubMed  Google Scholar 

Gorman JM (2003) New molecule targets for antianxiety interventions. J Clin Psychiatry 64:28–35

CAS  PubMed  Google Scholar 

Grivas V, Markou A, Pitsikas N (2013) The metabotropic glutamate 2/3 receptor agonist LY379268 induces anxiety-like behavior at the highest dose tested in two rat models of anxiety. Eur J Pharmacol 715:105–110

Article  CAS  PubMed  PubMed Central  Google Scholar 

Guimaraes FD, Beijamini V, Moreira FA, Aguiar DC, de Lucca ACB (2005) Role of nitric oxide in brain regions related to defensive reactions. Neurosci Biobehav Rev 29:1313–1322

Article  CAS  PubMed  Google Scholar 

Hallak JEC, Maia-de-Oliveira JP, Abrao J, Evora PR, Zuardi AW, Crippa JAS, Belmonte-de-Abreu P, Baker GB, Dursun SM (2013) Rapid improvement of acute schizophrenia symptoms after intravenous sodium nitroprusside. A randomized, double-blind, placebo-controlled trial. JAMA Psychiatry 70:668–676

Article  CAS  PubMed  Google Scholar 

Hammer MB, Robert S, Fruech BS (2004) Treatment-resistant posttraumatic stress disorder Strategies for intervention. CNS Spectr 9:740–752

Holt RL, Bruce Lydiard R (2007) Management of treatment-resistant panic disorder. Psychiatry 4:48–59

PubMed  PubMed Central  Google Scholar 

Imre G, Salomons A, Jongsma M, Fokkema DS, Den Boer JA, Ter Horst GJ (2006) Effects of the mGluR2/3 agonist LY379268 on ketamine-evoked behaviours and neurochemical changes in the dentate gyrus of the rat. Pharmacol Biochem Behav 84:392–399

Article  CAS  PubMed  Google Scholar 

Kalkman OH (1989) β-adrenoceptor blockade in rats enhances the ambulation induced by 5-HTIA receptor agonists. Eur J Pharmacol 173:121–125

Article  CAS  PubMed  Google Scholar 

Kalouda T, Pitsikas N (2015) The nitric oxide donor molsidomine induces anxiolytic-like behaviour in two different rat models of anxiety. Pharmacol Biochem Behav 138:111–116

Article  CAS  PubMed  Google Scholar 

Kessler RC, Petukhova M, Sampson A, Zaslavsky AM, Wittchen HU (2012) Twelve-month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States. Int J Methods Psychiatr Res 21:169–184

Article  PubMed  PubMed Central  Google Scholar 

Kirk RE (1968) Experimental design: procedures for the behavioral science. Brooks/Cole, Belmont, CA, USA

Google Scholar 

Kreye VAW, Reske SN (1982) Possible site of the in vivo disposition of sodium nitroprusside in the rat. Naunyn-Schmiedeberg’s Arch Pharmacol 320:260–265

Article  CAS  Google Scholar 

Larson EA, Accardi MV, D’Antoni M, Karimi B, Siddiqui TJ, Bowie D (2020) Nitric oxide signaling strengthens inhibitory synapses of cerebellar molecular layer interneurons through a GABARAP-dependent mechanism. J Neurosci 40:3348–3359

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lucki I, Wieland S (1990) 5-Hydroxytryptamine1A receptors and behavioral responses. Neuropsychopharmacology 3:481–493

CAS  PubMed  Google Scholar 

Müller CP, Carey RJ, Salloum JB, Huston JP (2003) Serotonin1A-receptor agonism attenuates the cocaine-induced increase in serotonin levels in the hippocampus and nucleus accumbens but potentiates hyperlocomotion: an in vivo microdialysis study. Neuropharmacology 44:592–603

Article  PubMed  Google Scholar 

Nicolaus S, Chao OY, Beu M, Henke J, Antke C, Wang AL, Fazari B, Mamlins E, Huston JP, Giesel FL (2023) The 5-HT1A receptor agonist 8-OH-DPAT modulates motor/exploratory activity, recognition memory and dopamine transporter binding in the dorsal and ventral striatum. Neurobiol Learn Mem 205:107848

Article  Google Scholar 

Orfanidou MA, Lafioniatis A, Trevlopoulou A, Touzlatzi N, Pitsikas N (2017) Acute and repeated exposure with the nitric oxide (NO) donor sodium nitroprusside (SNP) differentially modulate responses in a rat model of anxiety. Nitric Oxide 69:56–60

Article  CAS  PubMed  Google Scholar 

Papageorgoulis A, Fallon P, Mpalantes N, Papageorgouli D, Pitsikas N (2020) Repeated but not acute exposure with a low dose range of the nitric oxide (NO) donor sodium nitroprusside (SNP) induces anxiolytic-like behaviour in a dose-independent manner in two different rat models of anxiety. Nitric Oxide 99:1–6

Article  CAS  PubMed  Google Scholar 

Peristeri E, Pitsikas N (2022) Effects of low doses of different nitric oxide (NO) donors in rat models of obsessive-compulsive disorder (OCD) and posttraumatic stress disorder (PTSD). Nitric Oxide 129:1–7

Article  CAS  PubMed  Google Scholar 

Pitsikas N (2018) The role of nitric oxide (NO) donors in anxiety. Lights and shadows. Nitric Oxide 77:6–11